S. Chéradame

767 total citations
7 papers, 433 citations indexed

About

S. Chéradame is a scholar working on Oncology, Rheumatology and Molecular Biology. According to data from OpenAlex, S. Chéradame has authored 7 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in S. Chéradame's work include Colorectal Cancer Treatments and Studies (5 papers), Folate and B Vitamins Research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). S. Chéradame is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Folate and B Vitamins Research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). S. Chéradame collaborates with scholars based in France. S. Chéradame's co-authors include Patricia Formento, G. Milano, M C Etienne, Jean–Louis Fischel, M. Schneider, O. Dassonville, F Démard, N. Renée, Antoine Thyss and J. L. Formento and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

S. Chéradame

7 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Chéradame France 6 355 119 101 87 73 7 433
G Tunesi Italy 6 359 1.0× 100 0.8× 199 2.0× 48 0.6× 85 1.2× 18 513
Ji Min Park United States 8 278 0.8× 266 2.2× 194 1.9× 61 0.7× 252 3.5× 11 612
M Bertrand United States 8 280 0.8× 78 0.7× 82 0.8× 18 0.2× 95 1.3× 14 392
Zenia Saridaki Greece 10 145 0.4× 119 1.0× 77 0.8× 26 0.3× 94 1.3× 24 407
Naohiro Nose Japan 8 219 0.6× 118 1.0× 277 2.7× 52 0.6× 50 0.7× 23 406
Teruyuki Ikehara Japan 10 247 0.7× 97 0.8× 68 0.7× 11 0.1× 147 2.0× 49 439
R Rajaganeshan United Kingdom 11 147 0.4× 71 0.6× 52 0.5× 52 0.6× 163 2.2× 23 333
Mikihiro Kohno Japan 14 331 0.9× 143 1.2× 306 3.0× 12 0.1× 62 0.8× 67 633
Helena Taflin Sweden 10 166 0.5× 48 0.4× 49 0.5× 23 0.3× 52 0.7× 25 253
Hirofumi Satake Japan 7 330 0.9× 130 1.1× 300 3.0× 10 0.1× 100 1.4× 17 529

Countries citing papers authored by S. Chéradame

Since Specialization
Citations

This map shows the geographic impact of S. Chéradame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chéradame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chéradame more than expected).

Fields of papers citing papers by S. Chéradame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chéradame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chéradame. The network helps show where S. Chéradame may publish in the future.

Co-authorship network of co-authors of S. Chéradame

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chéradame. A scholar is included among the top collaborators of S. Chéradame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chéradame. S. Chéradame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ilc, Karine, J. L. Formento, Pierre Laurent‐Puig, et al.. (2004). Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. British Journal of Cancer. 90(2). 526–534. 89 indexed citations
2.
Chéradame, S., M Chazal, Jean–Louis Fischel, et al.. (1999). Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex®) and folylpolyglutamate synthetase activity. Anti-Cancer Drugs. 10(5). 505–510. 4 indexed citations
3.
Chéradame, S., M C Etienne, Patricia Formento, et al.. (1997). Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients.. Journal of Clinical Oncology. 15(7). 2604–2610. 22 indexed citations
4.
Chéradame, S., M C Etienne, M Chazal, et al.. (1997). Relevance of tumoral folylpolyglutamate synthetase and reduced folates for optimal 5-fluorouracil efficacy: Experimental data. European Journal of Cancer. 33(6). 950–959. 26 indexed citations
5.
Chazal, M, S. Chéradame, Jean–Louis Formento, et al.. (1997). Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.. PubMed. 3(4). 553–7. 22 indexed citations
6.
Etienne, M C, S. Chéradame, Jean–Louis Fischel, et al.. (1995). Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.. Journal of Clinical Oncology. 13(7). 1663–1670. 256 indexed citations
7.
Beck, Amy, M C Etienne, S. Chéradame, et al.. (1994). Wide range for optimal concentration of folinic acid in fluorouracil modulation—Experimental data on human tumour cell lines. European Journal of Cancer. 30(10). 1522–1526. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026